VELDHOVEN, the Netherlands—Big tech companies are gearing up to spend hundreds of billions of dollars on artificial-intelligence infrastructure. Their plans depend on a one-of-a-kind Dutch equipment ...

Google and YouTube sell billions in advertising every month. But now they’re partnering with SiriusXM to handle a specific bucket of inventory: audio ads that run against YouTube content like podcasts ...

Allen West’s resignation last week as Dallas County GOP chair, announced ahead of an executive committee meeting that was expected to call for his removal, should have closed a chapter of dysfunction ...

Taylor Swift and Travis Kelce attempted to make an incognito entrance to exclusive NYC hotspot Casa Cipriani. The lovebirds, both 36, were photographed on Friday night covering themselves with ...

Voters walk into the early voting center at the Franklin County Board of Elections in Columbus. Franklin County voters will see several key races on the primary election ballot this May, including ...

Kicking off a critical election year campaign, Pennsylvania House Republicans are proposing temporary tax breaks and other measures designed to address rising costs affecting consumers throughout the ...

SpaceX seems to be getting a step closer to a blockbuster initial public offering. Elon Musk’s aerospace firm has submitted its draft IPO registration to the U.S. Securities and Exchange Commission, ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

New tools in Gemini give users prompts to quickly copy over everything their previous chatbot knows about them. New tools in Gemini give users prompts to quickly copy over everything their previous ...

PROGRESS AND NEW INVESTMENTS UNDERWAY. WHETHER YOU ARE A CHEF IN LOUISIANA OR WHETHER YOU ARE DRIVING A VEHICLE IN MICHIGAN, CHANCES ARE IT STARTED IN THE PORT OF BALTIMORE, MARYLAND. ECONOMIC ENGINE ...

Abivax (ABVX) shares fell on Tuesday following the company’s 2025 financials, as its CEO suggested that the biotech is not rushing to pursue deals ahead of a key late-stage trial readout for its lead ...